Literature DB >> 1678948

A pilot study on the urinary excretion of porphyrins in human populations chronically exposed to arsenic in Mexico.

G G García-Vargas1, A García-Rangel, M Aguilar-Romo, J García-Salcedo, L M del Razo, P Ostrosky-Wegman, C Cortinas de Nava, M E Cebrián.   

Abstract

1 The aim of this pilot study was to investigate if the porphyrinuria produced by arsenic in rodents was present in humans chronically exposed to arsenic via drinking water. 2 The concentrations of uroporphyrin, coproporphyrin and total arsenic in urine were compared between 21 individuals exposed to arsenic in their drinking water (0.390 mg l-1) and 19 controls exposed to 0.012 mg l-1. 3 Arsenic-exposed individuals had significantly higher total arsenic concentrations in their urine than the control group. No increase in urinary porphyrin excretion was found in exposed individuals. However, an inversion of the coproporphyrin/uroporphyrin (COPRO/URO) ratio was observed in most exposed individuals. This inversion was caused both, by a decrease in coproporphyrin excretion and an increase in uroporphyrin excretion. 4 No demonstrable correlations between porphyrin excretion, the COPRO/URO ratio and total arsenic concentration in urine were found in exposed individuals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1678948     DOI: 10.1177/096032719101000307

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Urinary porphyrins in patients with endemic chronic arsenic poisoning caused by burning coal in China.

Authors:  Y Xie; M Kondo; H Koga; H Miyamoto; M Chiba
Journal:  Environ Health Prev Med       Date:  2001-01       Impact factor: 3.674

Review 2.  Environmental chemical exposures and disturbances of heme synthesis.

Authors:  W E Daniell; H L Stockbridge; R F Labbe; J S Woods; K E Anderson; D M Bissell; J R Bloomer; R D Ellefson; M R Moore; C A Pierach; W E Schreiber; A Tefferi; G M Franklin
Journal:  Environ Health Perspect       Date:  1997-02       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.